GOVERNANCE Composition of the Board of Directors Facebook Twitter LinkedIn Board of Directors The Board of Directors, appointed by the shareholders, is composed of 16 members, two of whom are employee representatives. 11 directors are independent. Members of our Board of Directors are appointed for a maximum term of four years; reappointment of Directors is done on a rotation basis. The Board of Directors defines the strategic business guidelines and directions of the Company, and supervises their implementation. Subject to the powers expressly attributed to the Shareholders’ General Meeting, and within the scope of the company’s corporate purpose, the Board of Directors’ powers cover all issues relating to the proper management of the company and through its decisions the Board determines all matters falling within its authority. Further information in our Board Charter Board diversity Each year, the Board of Directors conducts a review to ensure that there is an appropriate balance in its composition. In particular, the Board seeks to ensure gender balance and a broad diversity of backgrounds and countries of origin, international experience, reflecting Sanofi’s status as a diversified global business. As of May 2018, women represent 43% of members. 6 Directors are non-French. Above all, the Board seeks directors who show independence of mind and who are competent, dedicated and committed. Independence of board members Under the terms of the AFEP-MEDEF corporate governance code of listed corporations, a Director is independent when he or she has no relation of any kind whatsoever with the company, its group or its management that may interfere with his or her freedom of judgement. As of May 2018, 79% of members are independent. Composition of the Board of Directors To view all our images in high resolution, visit our Media Image Library page As of February 2019, the Board of Directors comprises the following members: Serge Weinberg* Chairman of the Board of Directors Director’s term ends: 2023 FURTHER INFORMATION Olivier Brandicourt Chief Executive Officer Director’s term ends: 2022 FURTHER INFORMATION Laurent Attal Director’s term ends: 2020 FURTHER INFORMATION Emmanuel Babeau* Director’s term ends: 2022 FURTHER INFORMATION Christophe Babule Director’s term ends: 2022 FURTHER INFORMATION Bernard Charlès* Director’s term ends: 2021 FURTHER INFORMATION Claudie Haigneré* Director’s term ends: 2020 FURTHER INFORMATION Patrick Kron* Director’s term ends: 2022 FURTHER INFORMATION Fabienne Lecorvaisier* Director’s term ends: 2021 FURTHER INFORMATION Melanie Lee* Director’s term ends: 2021 FURTHER INFORMATION Suet-Fern Lee* Director’s term ends: 2023 FURTHER INFORMATION Carole Piwnica* Director’s term ends: 2020 FURTHER INFORMATION Diane Souza* Director’s term ends: 2020 FURTHER INFORMATION Thomas Südhof* Director’s term ends: 2020 FURTHER INFORMATION * Independent Director Directors representing employees Marion Palme Director’s term ends: 2021 FURTHER INFORMATION Christian Senectaire Director’s term ends: 2021 FURTHER INFORMATION Summary table DIRECTOR AGE NATIONALITY FIRST APPOINTED TERM EXPIRES SENORITY AC AGC CC SC SCIC SERGE WEINBERG, CHAIRMAN OF THE BOARD(A) 68 French December 2009 2023 AGM 9 C C √ OLIVIER BRANDICOURT, CHIEF EXECUTIVE OFFICER 63 French April 2015 2022 AGM 4 √ LAURENT ATTAL 61 French May 2012 2020 AGM 7 √ √ EMMANUEL BABEAU(A) 52 French May 2018 2022 AGM 1 √ CHRISTOPHE BABULE 53 French February 2019 2022 AGM 0 BERNARD CHARLÈS(A) 62 French May 2017 2021 AGM 2 CLAUDIE HAIGNERÉ(A) 61 French May 2008 2020 AGM 10 √ √ PATRICK KRON(A) 65 French May 2014 2022 AGM 5 √ C √ FABIENNE LECORVAISIER(A) 56 French May 2013 2021 AGM 6 C MELANIE LEE(A) 60 British May 2017 2021 AGM 2 √ √ SUET-FERN LEE(A) 60 Singaporean May 2011 2023 AGM 8 MARION PALME(B) 36 German May 2017 2021 AGM 2 CAROLE PIWNICA(A) 61 Belgian December 2010 2020 AGM 8 √ CHRISTIAN SENECTAIRE(B) 54 French May 2017 2021 AGM 2 DIANE SOUZA(A) 66 American May 2016 2020 AGM 3 √ √ THOMAS C. SÜDHOF(A) 63 German/American May 2016 2020 AGM 3 C AC: Audit Committee AGC: Appointments and Governance Committee CC: Compensation Committee SC: Strategy Committee SciC: Scientific Committee C: Chairman/Chairwoman (a) Independent director (b) Director representing employees Follow us Sanofi on Twitter Sanofi TV on YouTube Sanofi On LinkedIn Sanofi on Instagram Sanofi RSS feeds Contact Sitemap Legal notice Privacy & Data Protection Cookies policy Corporate code of ethics Our websites Our publications © Sanofi 2004-2019 - All rights reserved This website uses cookies to track its audience and improve its content. By continuing to browse this website, you agree to the use of such cookies. CLICK HERE FOR MORE INFORMATION ON COOKIES OK